Today KLAS is pleased to announce the publication of a new report the examines meaningful use attestation. Some highlights from the study are below.
— Both large and small hospital vendors found success in the first year of meaningful use attestation.
— Depending on the vendor, some providers also saw a higher ROI for their meaningful use expenses than others, with the community hospitals covering their meaningful use costs more easily than larger IDNs.
— In certain areas all vendors performed poorly-even those like Epic, who might be expected to be ahead of the curve.
— Hospitals using Allscripts, Healthland, HMS, McKesson, and Siemens were slower to take off than others using Cerner, CPSI, Epic, and MEDITECH.
Small hospitals reach Stage 1 in large numbers and achieve greater incentive payment ROI; problem lists and quality measures level the playing field with large hospitals.
Orem, Utah – February 21, 2012 – CMS data shows that both large and small hospital vendors found success in the first year of meaningful use attestation. Hospitals using Allscripts, Healthland, HMS, McKesson, and Siemens were slower to take off than others using Cerner, CPSI, Epic, and MEDITECH. KLAS interviewed 104 providers who successfully attested for meaningful use to analyze their vendor successes and struggles in the study Meaningful Use Attestation 2012: Early Birds Take Flight.
Although large vendors like Cerner and Epic met already high expectations, some vendors on the CMS chart were more surprising. CPSI was a standout in the community space with 139 hospitals, second only to Epic in having the largest percent of their client base successfully attest. Though not without their challenges, community vendors Healthland and HMS also delivered significant numbers of successful clients.
Some large vendors-like Allscripts, McKesson, and Siemens-had successful attesters, but it was a small number compared to the size of their client base, for reasons detailed in the report.
KLAS reports that MEDITECH is both a success and a struggle for providers. While they have the highest number of successful attesters at 203, the bulk of their attesters came from one large IDN.
The report also examines some areas where all providers experienced challenges and all vendors performed poorly-even those like Epic, who might be expected to be ahead of the curve. Problem lists and reporting topped the list of provider frustrations. Depending on the vendor, some providers also saw a higher ROI for their meaningful use expenses than others, with the community hospitals covering their MU costs more easily than larger IDNs. Additionally, providers shared advice based on their experience with MU attestation.
To learn more about providers’ experiences attesting for meaningful use with their vendors, the report Meaningful Use Attestation 2012: Early Birds Take Flight is available to healthcare providers online for a significant discount off the standard retail price. To purchase, healthcare providers and vendors can visit www.KLASresearch.com/reports.
KLAS is a research firm specializing in monitoring and reporting on the performance of healthcare vendors. KLAS’ mission is to improve delivery by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from more than 4500 hospitals and more than 2500 clinics, KLAS delivers timely reports, trends, and statistics that provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, medical equipment, and infrastructure vendors. For more information, go to www.KLASresearch.com, email mailto:email@example.com, or call 1-800-920-4109 to speak with a KLAS representative. Follow KLAS on Twitter at www.twitter.com/KLASresearch.